{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T23:32:42Z","timestamp":1720654362547},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.anndiagpath.2016.07.008","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T17:29:53Z","timestamp":1471714193000},"page":"7-14","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population"],"prefix":"10.1016","volume":"25","author":[{"given":"Yalda B.","family":"Naeini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0005","series-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","first-page":"233","article-title":"Diffuse large B cell lymphoma, not otherwise specified","author":"Stein","year":"2008"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0010","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"15","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0015","series-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","first-page":"262","article-title":"Burkitt lymphoma","author":"Leoncini","year":"2008"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0020","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/PAS.0000000000000211","article-title":"High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified","volume":"38","author":"Hwang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"29","author":"Meyer","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0035","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.5858\/arpa.2014-0451-CP","article-title":"Practical applications in immunohistochemistry: evaluation of diffuse large B-cell lymphoma and related large B-cell lymphomas","volume":"139","author":"O'Malley","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/PAT.0000000000000076","article-title":"Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis","volume":"46","author":"Lynnhtun","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jclinpath-2015-203002","article-title":"Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases","volume":"69","author":"Agarwal","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0050","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1365-2559.2012.04351.x","article-title":"Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?","volume":"61","author":"Mationg-Kalaw","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2012.52","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation","volume":"25","author":"Montes-Moreno","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0060","series-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","first-page":"243","article-title":"EBV positive diffuse large B cell lymphoma of the elderly","author":"Nakamura","year":"2008"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0065","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein-Barr virus (EBV)\u2013associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0070","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/asheducation-2015.1.618","article-title":"Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach","volume":"2015","author":"Friedberg","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2012.09.017","article-title":"Cancer genetics and genomics of human FOX family genes","volume":"328","author":"Katoh","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0085","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1182\/blood-2010-10-312231","article-title":"Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1","volume":"117","author":"Craig","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0090","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0095","doi-asserted-by":"crossref","first-page":"13933","DOI":"10.18632\/oncotarget.4324","article-title":"Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma\u2014is it necessary?","volume":"6","author":"Ok","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0100","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.28664","article-title":"Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"120","author":"Ok","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2016.07.008_bb0105","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416300624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416300624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:34:27Z","timestamp":1568306067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913416300624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S1092913416300624"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.07.008","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}